Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Rivaroxaban
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Rivaroxaban 20mg tablets
0208020Y0AAACAC
|
Rivaroxaban | Rivaroxaban | Cardiovascular System | 608,593 |
|
Rivaroxaban 15mg tablets
0208020Y0AAABAB
|
Rivaroxaban | Rivaroxaban | Cardiovascular System | 223,961 |
|
Rivaroxaban 10mg tablets
0208020Y0AAAAAA
|
Rivaroxaban | Rivaroxaban | Cardiovascular System | 84,194 |
|
Rivaroxaban 2.5mg tablets
0208020Y0AAADAD
|
Rivaroxaban | Rivaroxaban | Cardiovascular System | 29,560 |
|
Xarelto 20mg tablets
0208020Y0BBACAC
|
Xarelto | Rivaroxaban | Cardiovascular System | 2,929 |
|
Rivaroxaban 20mg capsules
0208020Y0AAAHAH
|
Rivaroxaban | Rivaroxaban | Cardiovascular System | 1,060 |
|
Xarelto 15mg tablets
0208020Y0BBABAB
|
Xarelto | Rivaroxaban | Cardiovascular System | 615 |
|
Rivaroxaban 15mg capsules
0208020Y0AAAGAG
|
Rivaroxaban | Rivaroxaban | Cardiovascular System | 554 |
|
Rivaroxaban 10mg capsules
0208020Y0AAAIAI
|
Rivaroxaban | Rivaroxaban | Cardiovascular System | 518 |
|
Xarelto 10mg tablets
0208020Y0BBAAAA
|
Xarelto | Rivaroxaban | Cardiovascular System | 462 |
|
Rivaroxaban 1mg/ml granules for oral suspension sugar free
0208020Y0AAAFAF
|
Rivaroxaban | Rivaroxaban | Cardiovascular System | 454 |
|
Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets
0208020Y0AAAEAE
|
Rivaroxaban | Rivaroxaban | Cardiovascular System | 136 |
|
Xarelto 2.5mg tablets
0208020Y0BBADAD
|
Xarelto | Rivaroxaban | Cardiovascular System | 103 |
|
Xarelto 1mg/ml granules for oral suspension
0208020Y0BBAFAF
|
Xarelto | Rivaroxaban | Cardiovascular System | 17 |
|
Xarelto 15mg/20mg treatment initiation pack
0208020Y0BBAEAE
|
Xarelto | Rivaroxaban | Cardiovascular System | 8 |
|
Rivaroxaban 5mg/ml oral suspension sugar free
0208020Y0AAAJAJ
|
Rivaroxaban | Rivaroxaban | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.